Hepatic fibrosis 2022: Unmet needs and a blueprint for the future

Cited by (432)

Items 301–400 of 432

  1. LncRNA Snhg12/IGFBP3 axis is involved in liver fibrosis by promoting the proliferation and activation of mouse hepatic stellate cells
    Jingmao Liao, Qi Yuan, Lidan Luo, Xiaoxuan Hu, Zhengzheng Li, Zheng Zhang · 2024 · Journal of Cell Communication and Signaling
  2. Elucidation of the anti-fibrotic diseases mechanism of chelerythrine by integrative approach of network pharmacology and experimental verification
    Wei Han, Gui-yun Qian, Qinrong Wang, Jie Liu, Yongping Zhang, Jian Xu, Tingting Li, Zhe Li · 2024 · Natural Product Research
  3. C23 ameliorates carbon tetrachloride-induced liver fibrosis in mice
    Rong-Xing Tang, Xiao-Jun Xie, Yong Xiong, Li Su, Luo Chen, Yigang Wang · 2024 · World Journal of Hepatology
  4. Amniotic membrane modulates MMP9 and MMP12 gene and protein expression in experimental model of the hepatic fibrosis
    ANA PAULA DA S. ALVES, Roberta Jenniffer Maciel Teixeira, Raissa Monteiro da Silva, Renata de Azevedo Canevari, Luciana Barros Sant’Anna · 2024 · Anais da Academia Brasileira de Ciências
  5. Acetoacetate Ameliorates Hepatic Fibrosis by Targeting Peroxisome Proliferator-Activated Receptor Gamma to Restore Lipid Droplets in Activated Hepatic Stellate Cells
    Ya Zhou, Feixia Wang, Mengru Hu, Siwei Xia, Li Yang, Shizhong Zheng, Feng Zhang · 2025 · Pharmaceuticals
  6. Risk factors analysis for significant liver fibrosis of prenatally diagnosed choledochal cysts: a retrospective case-control study
    X F Zhuang, YuanBin He, Dianming Wu, Yifan Fang, Yu‐Hsuan Lin, Yan-Bing Huang · 2025 · Frontiers in Pediatrics
  7. Liver fibrosis as a major prognostic factor in chronic liver diseases and a key target for pharmacotherapy
    Мехтиев Сабир Насрединович, О. А. Мехтиева, Берко Олеся Михайловна, A. S. Lovitskiy · 2025 · Meditsinskiy sovet = Medical Council
  8. Assessment and Improvement of Patient Knowledge on Liver Cirrhosis Prevention Using Structured Teaching in a Hospital Setting
    Chetan Naik · 2025 · Nigerian Postgraduate Medical Journal
  9. Traditional uses, phytochemical constituents, pharmacological activities, toxicity, and quality control of Senecio cannabifolius Less.: A review
    Junge Li, Yuanlu Zhang, Yuxin Liu, Xinrui Wang, Ailing Jia, Qiuzhu Tang, Ye Qiu, Zhidong Qiu · 2025 · Journal of Ethnopharmacology
  10. PARPs in liver diseases
    Jiaxin Xia, Xiao Ping Tang, Qihua Zhu, Yizhu Xu · 2025 · npj gut and liver.
  11. Serum asprosin level is significantly lower in patients with liver cirrhosis than in those with non-cirrhotic chronic liver diseases
    Sichao Wang, Yan Wang, Shujun Zhang, Tao Li, Xinli Zhou, Li Chen · 2025 · Frontiers in Endocrinology
  12. Stem Cell Therapy for Inflammatory Diseases: Progress, Challenges, and Future Directions
    Chen Wu, Zhi‐Ping Jin, Shu‐Qiang Weng, Ji‐Min Zhu, Ling Dong · 2026 · MedComm
  13. RAB25 promotes hepatitis B virus-induced liver fibrosis progression through activation of the PI3K/AKT signaling pathway
    Jing Liu, Bingjie Liu, Xia Xie, Xin Yang, Qiong Liu · 2026 · Virus Research
  14. Decoupling multicellular activation circuits: MPDA-mediated co-delivery of quercetin/simvastatin for potent hepatic fibrosis reversal
    Lu Zhang, Huan Shen, Bo-Heng Liu, Tingting Liu, Yun Mei, Bin Li, Yang Liu, Gang Cao, Shuo Yu · 2026 · Chemical Engineering Journal
  15. Road map for primary hepatocyte qualification in human liver organ models
    Mahboubeh Varmazyad, Dillon C. Gavlock, Michael W. Castiglione, Richard DeBiasio, Gregory M LaRocca, Celeste E. Reese, Lawrence A. Vernetti, Mark E. Schurdak, Andrew M. Stern, D. Lansing Taylor et al. · 2026 · BMC Methods
  16. Asarinin alleviates hepatic fibrosis through TRα-STAT3 pathway: A new strategy by regulating liver microenvironment
    Jiaqi Yang, Shu-Ya Li, Peng Jiang, Guo-Li Wu, Zheng Luo, Xin Guo, Xue-Kun Liu, Haiming Sun, Yu-Chen Jiang · 2026 · Journal of Ethnopharmacology
  17. Retrospective analysis of predictors for significant hepatic inflammation in metabolic-associated fatty liver disease with chronic hepatitis B
    Long Hao Xu, Runyan He, Yan Neng Kang, Heng Hong Lin, Jia En Yang, Hua Xiao Chen, Xue Ting Huang, Xiao Lu Wu, Baohui Pei, Chao Zhou et al. · 2026 · PeerJ
  18. Rougan Granules ameliorates liver fibrosis through autophagy regulation: Insights from HPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation
    Meng-Chao Wen, Ji-Yue Li, QianQian Sun, Chen Hu, SuLan Ju, Fang Tian, Biqing Chen, Chenyao Li, YanMei Liu, Jin‐Yong Zhou et al. · 2026 · Journal of Chromatography B
  19. 6-Shogaol inhibits HSCs activation and liver fibrosis by regulating glycolytic reprogramming via targeting HIF-1α
    Jie Yang, M Z Shu, Hui Fang, F Y Yang, J R Li, Yuansong Sun, H H Li, Tao Xu · 2026 · Chinese Medicine
  20. Role of the gut microbiota–bile acid axis in liver fibrosis based on microbiomics and targeted metabolomics
    Yu-Lin Zhang, Hong-Zhong Gou, Zhen-Jiao Li, Jia-Hui Xi, Xiao-Juan Wang, Jin Shang, Dan Zhu, Longfei Ren, Xiao-Jun Shu, Lei Zhang (38117) · 2026 · BMC Microbiology
  21. Huaganjian decoction attenuates liver fibrosis via purine metabolic-inflammatory synergistic crosstalk: network pharmacology combined with multi-omics analyses
    Y Zhang, Wenjie Su, Wei Chen, Shen Yao, Shibin Chen, Siming Wang, Daqing Zhao, Huihui Liu, Meichen Liu · 2026 · Phytomedicine
  22. α-Ketoglutarate mitigates titanium dioxide nanoparticle-induced hepatotoxicity by reinforcing redox balance and PI3K-Akt activation
    Weimin Wang, Mengxuan Jia, Rongrong Zhang, Xue Ma, Qin Jin, Wenqi Zhang, Fangyuan Liu, Gang Liu · 2026 · Ecotoxicology and Environmental Safety
  23. Oleic acid modulates perilipin expression and lipid droplet contents in TGFβ1 activated HSCs
    Franco PS, Ghanshyam Sahu, Manish Mahawar, Elke Roeb, Karuna Irungbam · 2026 · Biochemical and Biophysical Research Communications
  24. Ferroptosis in liver diseases: molecular mechanisms, biomarker potential, and clinical translation
    Heng Tian, Yi Yang, Le Chen, Ran Wei, Wang Liu, Ying Liu, Jiaju Wang, Enba Zhuo, Kangsheng Gu, Jianwei Xing · 2026 · Frontiers in Cell and Developmental Biology
  25. Fibrosis regression in chronic liver disease: The pathologist’s view
    Alastair D. Burt, Cynthia Behling, Annette S.H. Gouw, Prodromos Hytiroglou, Carolin Lackner, Venâncio Avancini Ferreira Alves, Valérie Paradis, Young Nyun Park, Peter Schirmacher, DINA G. TINIAKOS · 2026 · Journal of Hepatology
  26. Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer
    Clemens Hinterleitner, Valentin J.A. Barthet, Hailey V. Goldberg, Kristen C. Vogt, Ana Marie Perea, Logan R. Hillger, Stephen B. Ruiz, Domhnall McHugh, Yu-Jui Ho, Almudena Chaves Perez et al. · 2026 · Science
  27. Perfil de un judeoconverso del Reino de Granada: el escribano Antón López de Toledo
    M. T. Beltrán · 2006 · Revista del Centro de Estudios Históricos de Granada y su Reino/Revista del Centro de Estudios Históricos de Granada y su Reino
  28. Collagens of the third and fourth types in various forms of alcoholic liver disease
    Ольга Петровна Дуданова, Алиса Сергеевна Родина, Марина Эдуардовна Шубина, Курбатова Ирина Валерьевна, Ludmila V. Topchieva · 2023 · Экспериментальная и клиническая гастроэнтерология
  29. In situ subtotal spleen resection combined with selective pericardial devascularization for the treatment of portal hypertension
    Hailin Li, Shanglei Ning, Yanjing Gao, Tao Zhou, Yuxin Chen · 2023 · World Journal of Gastrointestinal Surgery
  30. Farnesoid X receptor modulator 12β-( m -methyl-benzoyl)-11,12-dihydro oleanolic acid represses liver fibrosis by inhibiting ERK/p38 signaling pathways
    Yiming Li, Yunyang Bao, Simin Guo, Yang Li, Wei‐Shuo Fang, Na Zhang, Hongwei He · 2024 · Toxicology Mechanisms and Methods
  31. Analysis of the relationship between Cxcl12, Tweak, Notch1 and Yap1 mRNA expression in the molecular mechanisms of liver fibrogenesis
    E. I. Lebedeva, Anatoliy T. Shchastniy, Andrei S. Babenka, Dmitry Aleksandrovich Zinovkin · 2024 · Molecular Biology
  32. Second harmonic generation digital pathology with artificial intelligence: breakthroughs in studying fibrosis dynamics and treatment response
    Nikolai V. Naoumov, Elaine Chng · 2024 · Future Medicine AI
  33. Cpd861 Targeting BCL2 to Alleviate Hepatic Fibrosis: Network Pharmacology, Mendelian Randomization, and Molecular Docking Mechanisms
    Yaning Lyu, Xifeng Liang, Shuang Gao, Jing Li, Jinming Li, Shuhan Zhang, Chenghong Yin, Cheng Chi · 2024 · Current Pharmaceutical Design
  34. A Novel Nanoscale Phase-Change Contrast Agent Evaluates the Hepatic Fibrosis Through Targeting Hepatic Stellate Cell Platelet-Derived Factor Beta Receptor by Ultrasound in Vitro
    Hanmei Li, Linli Feng, Qiong Jiang, You Yang, Juying Zhang, Xia Luo, Xing Yang, Bo Ren, Li-tao Ye, Zheng-ju Hou et al. · 2024 · Ultrasound in Medicine & Biology
  35. Engineered Intelligent Microenvironment Responsive Prodrug Conjugates Navigated by Bioinspired Lipoproteins for Reversing Liver Fibrosis
    Mingzhu Fang, Boyu Su, Shilin Zhang, Fangxin Li, Yun Guo, Qinjun Chen, Yuxing Wu, Huiyi Liu, Chen Jiang, Tao Sun · 2025 · Small Methods
  36. Correlation of liver fibrosis quantification by morphometry using HepaScan with the analysis of liver biopsies. A pilot study
    Nathalie Alemán-García, José Antonio García-García, Marco A. Durán-Padilla, María E. Gutiérrez-Díaz-de Ceballos, Thelma Rizo-Pica, Ana del Carmen Susunaga Notario, Celia A. Sanchez-Perez · 2023 · Gaceta Médica de México
  37. Special Issue on “Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II”
    Ralf Weiskirchen · 2022 · Cells
  38. Persistence of fibrogenic process in direct-acting antiviral (DAA) treated patients?
    Cecilia Battistelli, Marco Tripodi · 2022 · ExRNA
  39. Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis: Molecular and Multicellular Control of Evolving Diseased States
    Jérôme Eeckhoute · 2022 · Cells
  40. Role of Sonoelastography in Evaluation of Liver Fibrosis: Review Article
    Omar Ahmed Abdellatif Ahmed · 2022 · The Egyptian Journal of Hospital Medicine
  41. Study on the Mechanism of Blood Circulation in Patients with Liver Fibrosis
    莉 田 · 2022 · Advances in Clinical Medicine
  42. Deep Learning Based Classiftcation of Normal and Hepatic Fibrosis Mouse Model Using Digital Pathology Images
    Ayesha Kousar, Shivam Damani, Priyanka Anvekar, Arush Rajotia, Keerthy Gopalakrishnan, Bhavana Baraskar, Vaishnavi Kalpesh Modi, Keirthana Aedma, Joshika Agarwal, Hima Varsha Voruganti et al. · 2022 · IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
  43. Correlación de la cuantificación de fibrosis hepática por morfometría mediante HepaScan con el análisis de las biopsias hepáticas. Estudio piloto
    Nathalie Alemán-García, José Antonio García-García, Marco A. Durán-Padilla, María E. Gutiérrez-Díaz-de Ceballos, Thelma Rizo-Pica, Ana del Carmen Susunaga Notario, Celia A. Sanchez-Perez · 2023 · Gaceta Médica de México
  44. Book Review: Weiskirchen, R.; Friedman, S.L. Hepatic Stellate Cells: Methods and Protocols, 1st Ed.; Weiskirchen, R., Friedman, S.L., Eds.; Methods in Molecular Biology 2669; Humana Press: New York, NY, USA, 2023; ISBN 978-1-07-163206-2; eISBN: 978-1-0716-3207-9
    Ralf Weiskirchen, Scott L. Friedman · 2023 · Livers
  45. Transcriptomic Enrichment of Ferroptosis-Related Gene ACSL4 in Advanced Hepatic Fibrosis/Cirrhosis: Bioinformatics Analysis and Experimental validation
    Shuya Zhang, Ying Liu, Liping Chen, Yuxuan Liu, Yuqi Guo, Jilin Cheng, Jun Huang · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Special Issue “Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment”
    Ralf Weiskirchen, Tilman Sauerbruch · 2023 · Livers
  47. Effect of mycophenolate mofetil alleviates carbon tetrachloride-induced liver fibrosis in mice.
    Peng Ding, Pengpeng Zhang, Hao Li, Yingzi Ming · 2023 · PubMed Central
  48. Difficulties in assessing portal hypertension in case of HVB-HVD co infection
    Manon Allaire, Charles Roux, Sepideh Akhavan, Pascal Lebray, Dominique Thabut · 2023 · Clinics and Research in Hepatology and Gastroenterology
  49. Matrix Gla Protein, a New Target Fighting Against Fibrosis of Nonalcoholic Steatohepatitis?
    Kaitlyn Hinz, Wen‐Xing Ding · 2023 · Cellular and Molecular Gastroenterology and Hepatology
  50. Alcoholic Fibrosis/Cirrhosis and Its Reversibility
    Massimo Pinzani · 2023 · Springer eBooks
  51. Wuling Capsule Modulates Macrophage Polarization by Inhibiting the TLR4-NF-κB Signaling Pathway to Relieve Liver Fibrosis
    Sujuan Ren, Rui Zhou, Zhishu Tang, Zhongxing Song, Nan Li, Xinbo Shi, Yanru Liu, Yajun Chu · 2023 · SSRN Electronic Journal
  52. Additional file 2 of Cyp4a12-mediated retinol metabolism in stellate cells is the antihepatic fibrosis mechanism of the Chinese medicine Fuzheng Huayu recipe
    Dabing Ping, Xin Sun, Yuan Yang Peng, Chenghai Liu · 2023 · Figshare
  53. Metabolic stress-induced dysregulation of the Hippo signaling pathway inhibits the occurrence of hepatocarcinoma
    Ziyi Li, Qianqian Tao, Wenshan Jing, Xingyang Lu, Qi Zhang, Gaobin Hu, Long yu Huang, Liangliang Zhang, Hui Peng, Qiyu Feng et al. · 2024 · Research Square
  54. Expression and clinical significance of MMP-13 in the liver of children with biliary atresia
    Xiangang Xiong, Zebing Zheng, Yuanmei Liu, Yu Liao, Xu-Dong Qin, Xiaohuan Zhao, Yuan Gong, Chengyan Tang, Zhu Jin · 2024 · Research Square
  55. Pathological and Ultrastructural Study on the Chronic Liver Damage Induced by Thioacetamide in Male Rats.
    Sohaila Abd El-Hameed, Iman Ibrahim, Walaa Fekri Awadin, Ahmed El-Shaieb · 2024 · Egyptian Journal of Veterinary Science
  56. Dietary Nutritional Supplements Are Associated with the Deterioration of Hepatic Fibrosis in Women and Individuals without Underlying Disease
    Minsu Cha, Sangheun Lee, Ki Jun Han · 2024 · International Journal of Environmental Research and Public Health
  57. R-Spondin Mimetic, SZN-043, Induced Proliferation and Expression of Wnt Target Genes, Two Impaired Features in Human Alcohol-Associated Liver Disease
    Trevor Fisher, Mehaben Patel, Shalaka Deshmukh, Darshini Shah, Chenggang Lu, Maureen R. Newman, Jay Ye, Russell B. Fletcher, Geertrui F. Vanhove, Jay Tibbitts et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Association between overt hepatic encephalopathy and liver pathology after transjugular intrahepatic portosystemic shunt creation in cirrhotic patients
    Chao-Yang Wang, Yuyang Gu, Guo-Feng Zhou, Peng-Fei Chen, Guo-Rui Zhao, Jian-Zhuang Ren, Wen-Guang Zhang, Huan-Zhang Niu · 2025 · Scientific Reports
  59. Assessment of hypoxia status in a rat chronic liver disease model using IVIM and T1 mapping
    Wenlu Dong, Longyang Xiao, Ziwei Luo, Haiyang Yu, Lili Wang, Yuanxiang Gao, Zhiming Li · 2025 · Frontiers in Medicine
  60. R-Spondin Mimetic, SZN-043, Induced Proliferation and Expression of Wnt Target Genes, Two Impaired Features in Human Alcohol-Associated Liver Disease
    Trevor Fisher, Mehaben Patel, Shalaka Deshmukh, Darshini Shah, Chenggang Lu, Maureen R. Newman, Jay Ye, Russell B. Fletcher, Geertrui F. Vanhove, Jay Tibbitts et al. · 2025 · eLife
  61. R-Spondin Mimetic, SZN-043, Induced Proliferation and Wnt Activity, Two Features Deficient in Human Alcohol-Associated Liver Disease
    Trevor Fisher, Mehaben Patel, Shalaka Deshmukh, Darshini Shah, Chenggang Lu, Maureen R. Newman, Jay Ye, Russell B. Fletcher, Geertrui F. Vanhove, Jay Tibbitts et al. · 2025 · eLife
  62. The Association Between Oxidative Balance Score and Liver Fibrosis: Evidence from NHANES 2007-2020
    Lunwei Yang, Fengyan Huang, Xiaoying S. Zhong, Xiongwen Wang · 2025 · Research Square
  63. Identification of CTSK as a TLR-related critical biomarker in liver cirrhosis via integrative bioinformatics and pathological characterization
    Jiaxin Wang, Ning Li, Xueyu Cang, Xuerong Liu, Ranyan Gao, Lingyi Xu, Fengchun Li, Xinyu Jiang, Hongliang Chen, Xinyu Geng et al. · 2025 · Scientific Reports
  64. Prunus mongolica oil attenuates hepatic fibrosis via a lncRNA-mediated ceRNA network targeting dual PGC-1α/PPARγ and TGF-β/Smad3 pathways
    YiJie Hou, Hong-Bing Zhou, XiaoGang Li, Jiaxing Gao, Hong Chang, Jia Wang, Yingchun Bai, Shuyuan Jiang, Shufang Niu, Wanfu Bai et al. · 2025 · Molecular Omics
  65. In-depth investigation into the binding capabilities of palladium-based N-heterocyclic carbenes towards five heavy metals: Hg, Cd, Pb, Cr, and As
    Qiao Liu, Xiang‐he Kong, Qian Li, Wenbo Lan · 2025 · PLoS ONE
  66. R-Spondin Mimetic, SZN-043, Induced Proliferation and Expression of Wnt Target Genes, Two Impaired Features in Human Alcohol-Associated Liver Disease
    Trevor Fisher, Mehaben Patel, Shalaka Deshmukh, Darshini Shah, Chenggang Lu, Maureen R. Newman, Jay Ye, Russell B. Fletcher, Geertrui F. Vanhove, Jay Tibbitts et al. · 2025 · eLife
  67. Emerging role of FUS in TGFB1 and COL1A1 transcription dependent on GADD45B to induce NASH-fibrosis
    Chi Wu, Qiang Ding, Zhilin Zeng, Longjun Yang, Xiaozhen Song, Miaoxin Zhang, Panpan Lu, Rui Zhu, Zhipeng Du, Yixing Luo et al. · 2025 · Journal of Molecular Cell Biology
  68. Additional file 1 of Cyp4a12-mediated retinol metabolism in stellate cells is the antihepatic fibrosis mechanism of the Chinese medicine Fuzheng Huayu recipe
    Ping, Da-bing, Sun, Xin, Peng, Yuan, Liu, Cheng-hai · 2023 · Figshare
  69. Additional file 1 of lncRNA Helf promotes hepatic inflammation and fibrosis by interacting with PTBP1 to facilitate PIK3R5 mRNA stabilization
    Han, Xiaohui, Beichen Guo, Zhao, Sicong, Li, Yehua, Zhu, Jing, Yifan He, Wang, Jiajun, Qingbin Yao, Shao, Shuai, Zheng, Lina et al. · 2023 · Figshare
  70. Additional file 1 of Placenta mesenchymal stem cell-derived extracellular vesicles alleviate liver fibrosis by inactivating hepatic stellate cells through a miR-378c/SKP2 axis
    Zheng, Wenjie, Saiyan Bian, Qiu, Shi, Colin Edward Bishop, Meimei Wan, Xu, Nuo, Xieyin Sun, Russel Clive Sequeira, Atala, Anthony, Gu, Zhifeng et al. · 2023 · Figshare
  71. Additional file 2 of Placenta mesenchymal stem cell-derived extracellular vesicles alleviate liver fibrosis by inactivating hepatic stellate cells through a miR-378c/SKP2 axis
    Zheng, Wenjie, Saiyan Bian, Qiu, Shi, Colin Edward Bishop, Meimei Wan, Xu, Nuo, Xieyin Sun, Russel Clive Sequeira, Atala, Anthony, Gu, Zhifeng et al. · 2024 · Figshare
  72. Additional file 2 of lncRNA Helf promotes hepatic inflammation and fibrosis by interacting with PTBP1 to facilitate PIK3R5 mRNA stabilization
    Han, Xiaohui, Beichen Guo, Zhao, Sicong, Li, Yehua, Zhu, Jing, Yifan He, Wang, Jiajun, Qingbin Yao, Shao, Shuai, Zheng, Lina et al. · 2024 · Figshare
  73. GMP-Compliant Manufacturing of [68Ga]Ga-ATH001 for a Human Microdose Trial Targeting Platelet-Derived Growth Factor Receptor Beta (PDGFRβ)
    Mélodie Ferrat, Antonios Tzorzakakis, Mohammad Mahdi Moein, Tetyana Tegnebratt, Ayman Abouzayed, Talakad Goolaiah Lohith, Per Hagmar, Emma Jussing, Rimma Axelsson, Jennie Engstrand et al. · 2025 · Research Square
  74. Plant-Derived miR-55 Alleviates Liver Fibrosis by Disrupting the CK2α/SMO Complex and Promoting SMO Ubiquitination
    Lei Wu, Jing Yang, Anqi Li, Yuqiang Zhao, Qing Liu, Zhenbo Li, Yihan Liu, Peng Tang, Rui Wang · 2026 · International Journal of Molecular Sciences
  75. Piezo1 signaling facilitates capillarization of LSECs and contributes to liver fibrosis progression
    Yang Xiang, Liyuan Gao, Yi Han, Yingchun Zhang, Xiaoyan Chang, Liwei Zhu, Ying Meng, Yanfei Ju, Yunjie Zheng, Ting Yang et al. · 2026 · Research Square
  76. Perspectives of Indian Gastroenterologists and Hepatologists on Nonalcoholic Fatty Liver Disease Diagnosis and Management: Insights From the Nationwide Web-Based Cross-Sectional DRIVE Survey
    Anil Arora, Yogesh Garje, Shagupta Shaikh, Shruti K. Dharmadhikari, Chintan Khandhedia, Neeraj Markandeywar, Amey Mane, Suyog C. Mehta, Ashish Kumar · 2026 · Interactive Journal of Medical Research
  77. Research Progress on the Effects and Mechanisms of Natural Active Components in Arctium lappa L. on Alleviating Hepatic Fibrosis
    海霞 谭 · 2026 · Advances in Clinical Medicine
  78. LGALS3BP in liver cirrhosis: a genetic-based discovery from platelet-related genes with predictive diagnostic value
    Shanshan Huan, Yuehua Chen, Huinan Lu, Xiaodan Fu · 2026 · Research Square
  79. The Role of MicroRNA Networks in Alcohol-associated Liver Disease
    Seol Hee Park, Wonhyo Seo · 2026 · Journal of Digestive Cancer Research
  80. Double-target responsive FRET sensor based on DNA tetrahedron for robust detection of liver fibrosis-related mRNAs in activated hepatic stellate cells
    Jinyong Wang, Jiayin Huang, Meiqin Zhang, Xinyao Liu, Yanlin Liu, Ya Zhang, Xiaodong Wang, Hongfei Zhou, Dazhi Chen, Zhifa Shen et al. · 2026 · Biosensors and Bioelectronics
  81. FOS drives podocyte injury and renal fibrosis in diabetic kidney disease via direct Smad3 binding
    Man Sun, Tianchi Yan, Wenjing Zhao, Zhifeng Cheng · 2026 · Cellular and Molecular Life Sciences
  82. Pilot Study on the Use of Rheology and Low Field Nmr to Characterize the Liver of Obese Patients Undergoing Metabolic and Bariatric Surgery
    Alice Biasin, Silvia Palmisano, Michela Abrami, Deborah Bonazza, Fabrizio Zanconati, Domenico Tierno, Federica Tonon, Nhung Hai Truong, Thanh Minh Dang, Ralf Weiskirchen et al. · 2026 · International Journal of Molecular Sciences
  83. Taraxasterol alleviates liver fibrosis by suppressing hepatic stellate cell activation via the HSD11B1-ERK MAPK signaling axis
    Peng Wang, 周浩雄, Yuming Ding, Yan Chen, Huiling Liu, Jie Jiang, Bin Wu · 2026 · Acta Biochimica et Biophysica Sinica
  84. Integrative approach to alcohol-related liver fibrosis: natural compounds modulating oxidative stress and ferroptosis
    Afrah F. Salama, Alaa Elmetwalli, Amro E. Mohamed, Lobna Mohamed Elashry, Ghada M. Al‐Ashmawy · 2026 · 3 Biotech
  85. Metabolism-modulating nanoparticles for remodeling adipose-liver crosstalk to reverse liver fibrosis
    Ling-Feng Zhang, Su-Qing Liang, Qing‐Wen Huang, Jia-Wen Ru, Ze-Quan Ding, Chun-Yu Zhang, Yi Wang, Tian‐Jiao Zhou, Lei Xing, Xian Wu Cheng et al. · 2026 · Journal of Controlled Release
  86. Alhagi honey polysaccharide ameliorates carbon tetrachloride-induced liver fibrosis via modulating the gut microbiota-liver metabolism axis
    Jianzhong Song, Xin Zhao, Lingling Cao, Yingying Chen, Xingchen Zhou, Jinfa Li, 有培 金, Jing Zhou, Zhiyuan Lv, X F Ma et al. · 2026 · Frontiers in Nutrition
  87. Chrono-metabolic regulation of hepatic fibrosis via NR1D1-mediated hepatic stellate cell activation
    Hou-Shu Tu, Meng-Lin Chen, Jing Hong, Ling He · 2026 · World Journal of Hepatology
  88. Emerging signal transduction pathways and the role of bacterial extracellular vesicles linked to the pathogenesis of endometriosis
    Ayako Muraoka, Akira Yokoi, Hiroaki Kajiyama · 2026 · Communications Medicine
  89. PPARγ signalling pathway: molecular mechanisms and therapeutic potential in ligamentum flavum hypertrophy and lumbar spinal stenosis
    Xue Chen, Chen Zhu, Shuhan Yang, Yuan Zeng, Bo Zhang, Chen Liang, Ye Tian, Tuanjiang Liu, Shanxi Wang · 2026 · Journal of Translational Medicine
  90. Emerging Trends and Research Hotspots in Gut Microbiota–Liver Fibrosis Research (2008–2025): A Bibliometric Analysis
    Yinpei Tang, Zhengwang Zhu, Linjing She, Pingsheng Zhu · 2026 · Journal of Nutrition
  91. Integrative and interpretable machine learning framework for early non-invasive detection of clinically significant liver fibrosis
    Dong Cao, Junjie Wang, Chenxi Hou, Jingyu Zeng, Baiyue Tian, Yuan Liu, X H Luo, Jiaxin Tian, Mingbo Zhou, Pan Li et al. · 2026 · Frontiers in Medicine
  92. Elucidating the multi-target mechanisms of Danggui Biejia decoction against hepatic fibrosis: An integrated network pharmacology and experimental study
    Chang Guo, ChengZhi Yang, JieWen Zhang, YiYang Li, Xili Wu · 2026 · European Journal of Integrative Medicine
  93. Dual regulatory roles and mechanisms of Gamma delta T cells in organ fibrosis
    Yongrong Li, Mingli Chen, Chaochao Chen, Dongchun Liang, Deming Sun, Zhoutao He, 蓝程 · 2026 · Tissue and Cell
  94. Microbiota-fibroblasts interactions in multi-organ fibrosis
    Caiyu Qi, Zhen Lin, Yuyang Gan, Peirong Liang, Lu Chen, Yuxuan Luo, Evan Sweren, Martin Prince Alphonse, Lan Yang, Luis A. Garza et al. · 2026 · Microbiological Research
  95. Natural Flavonoids as Potential Modulators of Liver Fibrosis: A Review of Mechanisms and Therapeutic Targets
    Jia Liu, Yi Han, Lingli Chen, Yifei Chen, Haiping Liang, Hui Chen, Wenbing Hu, Suyun Lin, Wenjun Wang · 2026 · Journal of Future Foods
  96. Phytocarbon Dots as an Oral Nano-Degrader of ENO1 for Alleviating Hepatic Fibrosis
    Lin Gao, Teng Liu, Yi-Kun Li, Ping Huang, J Y Li, Hongli Gao, Jingxin Li, Jun-Xia Zheng, Zhiyuan Lu · 2026 · Research Square
  97. Integrative Transcriptomics Across Etiologies Reveals Common and Disease‐Specific Fibrogenic Signatures in Liver Fibrosis
    Wen-Yan Yang, Long Li, Ya-Mei Ye, Chun Lin, Cheng Zhang, Hai-Bin Tu · 2026 · Canadian Journal of Gastroenterology and Hepatology
  98. Evaluation of the Therapeutic Potential of Spirulina Polysaccharides on Carbon Tetrachloride-Induced Liver Fibrosis in Mice: A Study Based on the Interaction Between Gut Microbiota and Metabolites
    Min Li, Songyao Xu, Meiting Zhang, Xin Wang, Siyan Wang, Xinle Wang, Ruiping Hu, Huiting Xue · 2026 · Nutrients
  99. Gut‐Derived Sodium Butyrate Attenuates Liver Fibrosis by Inhibiting Aerobic Glycolysis via the HDAC3/c‐Myc Signaling Axis
    Yong Sun, Hua-Yue Wu, Yu-Tong Zhou, Peng Yin, Long Wu, Haiyang Li, Shi Zuo, Zhe Yang, Kun Cao · 2026 · The FASEB Journal
  100. Nutraceuticals for the prevention of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD)
    Muhammad Yasir Naeem, Tabinda Ijaz · 2026 · Food Science and Biotechnology